Testing a rapid test for Candida auris
Part of Immune system & allergy, Infections clinical trials.
This trial is testing a rapid test to detect Candida auris, a hard-to-treat fungus. You can join if your doctor suspects you have this infection or you're being checked for it on your skin, and your lab sample is grown on specific plates or broths.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a suspected Candida auris infection (in blood or tissue) or be checked for skin colonization.
- If you have an infection, your sample must be grown on special lab plates used in the hospital (Sabouraud-dextrose and CHROMagar).
- If you are being checked on the skin, your sample must be grown on a salt-based broth (SSDB) and a standard liquid medium.
- No other limits – most people with a suspected Candida auris issue can join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a nasal antiseptic can reduce or prevent Candida auris infections in people who have had this germ before. It aims to find a simple way to lower the risk of future infection.
This study looks at patients in the intensive care unit who have a new infection with Candida (a type of fungus) despite taking strong antibiotics. It aims to better understand and diagnose these serious infections.
This study tests whether getting antibiotic resistance test results faster (within 6 hours) helps doctors choose the right antibiotic sooner for ICU patients with bloodstream infections caused by certain bacteria. Faster, accurate treatment may lead to better outcomes.
This study looks at whether a rapid test can help doctors detect CPE bacteria (which are resistant to many antibiotics) sooner, and whether using infection control measures can stop these bacteria from spreading. It may help you get the right care and reduce the risk of infection while in the hospital.
This trial tests a new rapid test that can quickly identify the cause of a severe infection (sepsis) in ICU patients. The goal is to see if faster results help doctors choose the right treatment sooner.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
Hear when a new Candida Auris Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.